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Background: The milk-derived protein human Casein alpha s1 (CSN1S1) has recently been detected in blood cells
and was shown to possess proinflammatory properties. In the present study, we investigated the effect of CSN1S1
on the differentiation of monocytes.
Methods: Primary human monocytes were stimulated with recombinant CSN1S1 and compared to cells stimulated
with GM-CSF/IL-4 or M-CSF/IFNγ. Morphological changes were assessed by microscopy and quantification of surface
markers of differentiation by FACS analysis. Phagocytic activity of CSN1S1 stimulated cells was measured by
quantification of zymosan labeled particle uptake. The role of mitogen activated protein kinases for CSN1S1-induced
differentiation of monocytes and proinflammatory cytokine expression was assessed by supplementation of
specific inhibitors.
Results: CSN1S1 at a concentration of 10 μg/ml resulted in morphological changes (irregular shape, pseudopodia) and
aggregation of cells, comparable to changes observed in M-CSF/IFNγ differentiated macrophages. Surface marker
expression was altered after 24 h with an upregulation of CD14 (mean 2.5 fold) and CD64 (1.9 fold) in CSN1S1
stimulated cells. CSN1S1 treated cells showed a characteristic surface marker pattern for macrophages after 120 h of
incubation (CD14high, CD64high, CD83low, CD1alow) comparable to changes observed in M-CSF/IFNγ treated monocytes.
Furthermore, phagocytic activity was increased 1.4 and 1.9 fold following stimulation with 10 μg/ml CSN1S1 after 24
and 48 h, respectively. Early GM-CSF, but not GM-CSF/IL-4 induced differentiation of monocytes towards dendritic cells
(DC) was inhibited by addition of CSN1S1. Finally, CSN1S1 induced upregulation of CD14 was impeded by inhibition of
ERK1/2, while inhibition of the mitogen activated protein kinases JNK and p38 did not influence cellular differentiation.
However, JNK and p38 inhibitors impeded CSN1S1 induced secretion of the proinflammatory cytokines IL-1b or IL-6.
Conclusions: CSN1S1 skews in vitro differentiation of monocytes towards a macrophage-like phenotype. Data is
accumulating that functions of CSN1S1 are beyond nutritional properties and include immunomodulatory effects.
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Human milk contains numerous proteins with properties
beyond nutritional function [1]. Caseins are a main pro-
tein constituent of human milk and casein fragments exert
a number of biological effects including the modulation of
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distribution, and reproduction in any mediuminhibition of cell growth [7,8] for instance. More re-
cently, a member of the casein family, casein alpha s1
(CSN1S1), was shown to be expressed outside the mam-
mary gland: overexpression was noted in lymph nodes
of encephalomyelitic mice and blood of multiple scler-
osis patients [9]. Furthermore, independent studies
reported overexpression of CSN1S1 in synovial tissue of
patients with osteoarthritis and rheumatoid arthritis
[10-12]. Consequently, a potential function of CSN1S1 was
further characterized by the finding of proinflammatoryCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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pression of IL-1β [13]. Thus, the concept of CSN1S1 as a
multifunctional protein with both nutritional and immuno-
modulatory functions is evolving. Initial events in many in-
flammatory conditions crucially involve macrophages [14].
Macrophages usually originate from monocytes that are
produced in the bone marrow and reach target tissues via
systemic circulation [15]. In the present study, we therefore
investigated the effect of CSN1S1 on monocytes and pos-
sible effects on cellular differentiation in vitro.
Methods
Blood donors and monocyte isolation
Cells were isolated from 40–60 ml peripheral blood of
healthy donors, collected into EDTA tubes (BD Bioscience,
Plymouth, UK) by magnetic cell sorting with beaded CD14
antibodies (Miltenyi Biotec, Bergisch Gladbach, Germany).
The number of experiments is indicated in the figure leg-
ends. Donors had to be free of any medication including
over-the-counter drugs, without record of any chronic ill-
ness, and currently free of any acute illness such as infec-
tions. Cells were seeded out at 1 × 106/ml except for
Western Blotting for extracellular signal-regulated kinase
(ERK) and c-jun N-terminal kinase (JNK) experiments,
cells were seeded out at 3 × 106/ml. The experiments were
conducted with the understanding and the consent of each
participant. The study was approved by the ethics commit-
tee of the medical faculty of Heinrich-Heine-University.
Cell culture and stimulation experiments
Monocytes were cultured in RPMI 1640 + GlutaMAX™
supplemented with 10% heat inactivated fetal bovine
serum, 50 IU/ml penicillin, and 50 μg/ml streptomycin
(Invitrogen, Karlsruhe, Germany). 30 μg/ml polymyxin
(Sigma-Aldrich, Munich, Germany) was added to experi-
ments to exclude any LPS effects (Sigma-Aldrich) [13], ex-
cept for the assessment of cellular morphology of living
cells, where 200 ng/ml LPS was added in a control experi-
ment. Recombinant human casein alpha S1 (CSN1S1)
(Calbiochem, Darmstadt, Germany) was added to cultured
cells in indicated concentrations for 24 or 120 h. The
following compounds were used to induce in vitro differ-
entiation of monocytes as control experiments: M-CSF
(R&D Systems, Wiesbaden, Germany) 50 ng/ml, GM-CSF
50 ng/ml, IL-4 20 ng/ml, IFNγ 10 ng/ml (all CellGenix,
Freiburg, Germany). For inhibition of casein effects, 20
μmol/l mouse anti human M-CSF antibody (R&D Sys-
tems) or cell permeable inhibitors were added as described
[13] (all from Calbiochem): briefly, p38 mitogen-activated
protein kinase (MAPK)-inhibitor ML3403 was used at 400
nM, ERK 1/2-inhibitor PD98059 was used at 50 μM, JNK-
inhibitor (JNK-inhibitor II) was used at 20 μM. Viability of
cells was assessed by 3-(4,5-dimethylthiazol-2-yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium-assay (Promega, Mannheim, Germany) according to the
manufacturer’s instructions.
Phagocytosis assay
Primary human monocytes were seeded out at 1 × 106/ml
and stimulated for 24 h with 1 μg/ml CSN1S1 in the pre-
sence of 30 μg/ml Px in order to exclude any LPS effects.
The uptake of fluorescent labelled zymosan particles was
assessed with the colorimetric Cytoselect Phagocytosis
Assay (Cell Biolabs, San Diego, CA, USA) according to
the manufacturer’s instructions after 24 and 48 h. As a
control, cells were cultured in medium including Px only.
Microscopy
Living cells were photographed at a scale of 400× magnifi-
cation with Nikon Eclipse TE300 and Nikon Digital Camera
DXM 1200 (Nikon, Düsseldorf, Germany) or cells were cul-
tured in chamber slides (Nunc, Rochester, NY, USA), May-
Grünwald-Giemsa stained (Merck, Darmstadt, Germany)
and photographed at a scale of 200 and 400× magnification
with Axioskop 2 Plus (Zeiss, Jena, Germany) and Nikon
Digital CameraDS-2Mv (Nikon).
Flow cytometry
Antibodies were purchased from BD Bioscience (CD14-
FITC, CD64-PE, CD83-FITC, CD1a-PE), R&D (CD115-
PE), and Biolegend (San Diego, CA, USA: CD116-FITC).
After stimulation, cells were incubated with the above
antibodies at optimized concentrations. For the assess-
ment of CSN1S1 effects on DC differentiation, primary
human monocytes were incubated with 50 ng/ml GM-
CSF or 50 ng/ml GM-CSF plus 20 ng/ml IL-4 in the ab-
sence or presence of 10 μg/ml CSN1S1. Surface-marker
expression was analyzed with FACSort (BD Biosience).
Depending on the mean fluorescence intensity, the expres-
sion of markers is defined as “low” at < 100 and as “high”
at > 100 [15].
Polymerase-chain-reaction (PCR)
RNA was isolated with Rneasy® Mini Kit (Qiagen, Hilden,
Germany), and reverse transcription was performed using
QantiTect® Reverse Transcription Kit (Qiagen) according
to the manufacturer’s instructions. PCR with real time
measurement of fluorescence was carried out on the
StepOnePlus Real-time PCR system (Applied Biosystems,
Foster City, CA, USA) with 0.3 μM gene-specific, exon-
spanning primers for IL-1b [GenBank: NM_000576.2] (Fw:
GGGCCTCAAGGAAAAGAATC, Rv: TTCTGCTTGAG
AGGTGCTGA) in triplicates using Qantitect® SYBR Green
PCR Kit (Qiagen). Results were relatively quantified
using glyceraldehyde-3-phosphate dehydrogenase GAP
DH [GenBank NM_002046.3] (Fw: CCAGCCGAGC
CACATCGCTC, Rv: ATGAGCCCCAGCCTTCTCC
AT) as internal and reference RNA (Stratagene, La
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Enzyme-linked immunosorbent assay
Quantikine® Human M-CSF-, IL-6- and IL-1-ELISA
(R&D Systems) were applied for measuring proteins in
the supernatants of cell cultures according to the ma-
nufacturer‘s instructions. Determinations were carried out
in duplicates. Absorbance was measured at 450 nm using
the Anthos 2001 ELISA reader (Anthos Mikrosysteme,
Krefeld, Germany).
Western blot
Western blot was carried out as described before for de-
tection of p38 [16], and JNK or ERK [17]. Briefly, after
stimulating primary human monocytes for 24h with 10
μg/ml CSN1S1 total cell proteins were prepared for SDS-
PAGE on a 12.5% gel. Electroblotting was carried out onto
a polyvinyldifluoride membrane (Porablot; Macherey-
Nagel, Düren, Germany). Membranes including the same
samples were incubated with either p38-MAP kinase
antibody (GeneTex, Eching, Germany) or phosphory-
lated p38-MAP kinase antibody, JNK or phosphory-
lated JNK antibody, and ERK or phosphorylated ERK
antibody (all Antibodies-online, Aachen, Germany) at
optimized concentrations over night at 4°C. After ap-
propriate washing procedures, the membranes were
incubated with a 1:10,000 dilution of horseradish per-
oxidase (HRP)-conjugated anti-rabbit IgG (Sigma).
Proteins were visualized via enhanced chemilumines-
cence (ECL) substrate (Santa Cruz Biotechnology,
Santa Cruz, California) and detection by CCD camera
(Intas Chemilux ECL Imager).
Data presentation
Data is presented as error-bars representing mean and
standard deviation, representative FACS histograms, or
representative photographs of microscopy slides and im-
munoblots. Data comparison was carried out by two-sided
T-test with Bonferroni correction for multiple testing for
comparison of surface markers after stimulation with
CSN1S1 only, or by one way ANOVA with Bonferroni cor-
rection for multiple testing in experiments with inhibitors,
antibodies, or when CSN1S1 stimulation was compared to
GM-CSF/IL4 or M-CSF/IFNγ stimulation. P < .05 was
considered significant.Results
CSN1S1 alters the morphology of monocytes
After incubation of primary human monocytes with re-
combinant CSN1S1, changes in cellular morphology
were noted. Living cells became adherent to the cell cul-
ture dish when incubated for 24 h with 1 μg/ml CSN1S1and the development of pseudopodia was noted in some
of the cells when stimulated with higher concentrations
(Figure 1). These effects were not observed in the control
cultures without CSN1S1, or in case lower concentrations
of CSN1S1 (1 ng/ml or 100 ng/ml) were used (data not
shown). For comparison, primary human monocytes were
incubated with up to 200 ng/ml LPS, which had no visible
effect on cellular morphology (Figure 1).
For a better characterization of cellular morphology, pri-
mary cells were cultured in chamber slides and stained.
Morphology of living cells suggested a differentiation to-
wards DC or macrophages. Thus, we included primary
cells stimulated with GM-CSF or GM-CSF/IL4, and M-
CSF or M-CSF/IFNγ for comparison to CSN1S1, as the
latter stimulants are known to mediate in vitro differenti-
ation towards the respective cell types [18,19]. Although
we observed rapid morphologic changes in CSN1S1 sti-
mulated cells, in vitro differentiation of monocytes is com-
monly carried out over 5 days. Thus, cells were incubated
with the stimulants for both, 24 h and 120 h. As can be
seen in Figure 2, after 24 h, control cells were round with
little cytoplasm. In contrast, GM-CSF and GM-CSF/IL-4
induced enlarged cytoplasm. M-CSF stimulated cells
displayed a smaller increase in cytoplasm with respect to
cells stimulated with GM-CSF or GM-CSF/IL4. Moreover,
M-CSF, and especially M-CSF/IFNγ treated cells displayed
pseudopodia, which were absent in control cells or cells
treated with either GM-CSF or GM-CSF/IL4. Further-
more, cells stimulated with M-CSF/IFNγ formed small
aggregates. These modifications observed in M-CSF or
M-CSF/IFNγ stimulated cells were similar to changes
observed in cells stimulated with CSN1S1, which formed
aggregates and developed pseudopodia. After 120 h, many
control cells became adherent and showed a greatly en-
larged cytoplasm. This was also observed for GM-CSF
and GM-CSF/IL-4 treated cells. Stimulation with M-
CSF caused the development of pseudopodia besides
the occurrence of adherent cells with enlarged cytoplasm.
The addition of IFNγ to M-CSF again led to a strong
tendency towards cellular aggregation and the develop-
ment of pseudopodia. This was also true for cells incu-
bated with CSN1S1.
CSN1S1 alters cell-surface marker expression
The cellular morphology of CSN1S1 stimulated cells sug-
gested a differentiation, either into macrophages or into
DC. Besides morphological changes, differentiated cells of
each type can be distinguished by distinct surface marker
expression [18,19]. Therefore, primary human monocytes
were incubated for 24 or 120 h with recombinant CSN1S1
and expression of representative surface markers for diffe-
rentiation of monocytes towards macrophages or DC were
analyzed by flow cytometry after immunolabeling. After
24 h stimulation with 10 μg/ml CSN1S1, upregulations of
control CSN1S1








Figure 1 Live primary human monocytes stimulated with CSN1S1. Primary human monocytes were incubated with CSN1S1 for 24 h with
increasing CSN1S1 concentrations in comparison to medium control and 200 ng/ml LPS. Living cells were photographed at 400× magnification.
Cells developed irregular cytoplasm (arrow) and pseudopodia (arrow-head). Representative pictures of 10 experiments.
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detectable (Figure 3a). Lower concentrations of CSN1S1
had no effect (data not shown). The pattern of surface
markers obtained was characteristic for macrophages ra-
ther than for DC (CD14high, CD64high, CD83low, CD1alow )
[15,18,19]. After 120 h of incubation with CSN1S1, CD14
but not CD64 remained significantly upregulated. The pat-
tern of surface markers remained the same (CD14high,
CD64high, CD83low, CD1alow) (Figure 3b). Next, we com-
pared the surface markers of monocytes differentiatedFigure 2 May-Grünwald-Giemsa stain of primary human monocytes s
in medium (control), with indicated cytokines, or CSN1S1 for 24 h or 120 h
pseudopodia, similar to cells stimulated with M-CSF/IFNγ. Cells were photo
10 experiments.with CSN1S1 to in vitro differentiated monocytes towards
macrophages (M-CSF/IFNγ) or DC (GM-CSF/IL-4). Such
differentiation is known to be obtained by stimulation of
primary human monocytes for 120 h [20]. As can be seen
in Figure 3c, no difference in surface marker expression
was observed after 24 h. In contrast, after 120 h, CSN1S1
and M-CSF/IFNγ stimulation resulted in the same pheno-
type (CD14high, CD64high, CD83low, CD1alow), while GM-
CSF/IL-4 caused a significant downregulation of CD14
and CD64 expression with upregulation of CD1a.timulated with CSN1S1. Primary human monocytes were incubated
. CSN1S1 stimulated cells formed aggregates and developed







































































































































Figure 3 (See legend on next page.)
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Figure 3 FACS-Analysis of CSN1S1 stimulated cells. Surface markers of differentiation in CSN1S1 stimulated monocytes. a, b. Mean and SD of
6 experiments and representative flow cytometry data after 24 and 120 h of CSN1S1 stimulation or cells kept in medium only (control). *
indicates p < 0.05 according to two-sided t-test with Bonferroni correction for multiple testing. c. Stimulation with CSN1S1 was compared to
differentiation towards macrophages (M-CSF/IFNγ) or dendritic cells (GM-CSF/IL-4) after 24 and 120 h (mean and SD of 6 experiments). * indicates
p < 0.05 according to ANOVA with Bonferroni correction for multiple testing.
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Next, we assessed if incubation of primary human mono-
cytes with CSN1S1 also results in functional changes. In-
creased phagocytic activity is a characteristic property of
monocytes differentiated towards a macrophage-like phe-
notype [18,19]. Therefore, the intracellular uptake of la-
belled zymosan particles into primary human monocytes
was assessed in a colorimetric assay after incubation with
10 μg/ml CSN1S1 for 24 h. There was a marked increase
in phagocytic activity of cells after 24 h (1.4-fold ± 0.4),
which was sustained after 48 h (1.9-fold ± 0.5, Figure 4a).
Influence of CSN1S1 on GM-CSF- and GM-CSF/IL-4-
induced DC differentiation
The above data suggested that CSN1S1 skews cellular
differentiation of monocytes towards a macrophage-like
phenotype. We were therefore interested, if an alterna-
tive route of differentiation, i.e. early differentiation of
monocytes into DC, could be antagonized by the
addition of 10 μg/ml CSN1S1 for 24 h. For this purpose,
primary human monocytes were incubated with GM-
CSF for 24 h in the presence or absence of CSN1S1 and
the expression of cell surface markers was assessed by
flow cytometry. As can be seen in Figure 4b, GM-CSF
alone induced a characteristic immature DC cell surface
marker pattern (CD14low, CD64low, CD83low, CD1ahigh)
[15]. The addition of CSN1S1 abolished GM-CSF effects
and lead to a macrophage pattern (CD14high, CD64high,
CD83low, CD1alow). Besides GM-CSF, the combination of
GM-CSF and IL-4 is a strong stimulus for in vitro DC
generation [15]. Therefore, we additionally examined the
properties of CSN1S1 in influencing GM-CSF/IL-4-in-
duced DC differentiation. GM-CSF/IL-4 similarly caused
characteristic immature DC cell surface marker expres-
sion (CD14low, CD64low, CD83low, CD1ahigh) after 24 h
of incubation, and this effect could not be inhibited by
the addition of CSN1S1 (data not shown).
The role of M-CSF in CSN1S1-mediated cellular
differentiation
We previously reported that monocytic cells secrete GM-
CSF in response to CSN1S1 [13]. GM-CSF is known to in-
fluence the differentiation of monocytes towards a DC
phenotype [21]. According to the present results, auto-
crine stimulation with CSN1S1 induced GM-CSF must
therefore be overcome by alternative stimuli to allow for a
differentiation towards the observed macrophage-likephenotype. We speculated that autocrine stimulation with
M-CSF secreted upon CSN1S1 induction, upregulation of
the M-CSF receptor CD115, or downregulation of the
GM-CSF receptor CD116 could be responsible for the ob-
served effects. First, primary human monocytes were sti-
mulated with 10 μg/ml CSN1S1 for 24 h and M-CSF
secretion into supernatants was quantified by ELISA. As
can be seen in Figure 4c, CSN1S1 increased the secretion
of M-CSF into culture supernatants 29-fold. As a control,
an M-CSF antibody was added to the experiments in order
to demonstrate its capacity to bind all secreted M-CSF
after stimulation (Figure 4c). In the next step, differenti-
ation of primary human monocytes was induced by 24 h
incubation with 10 μg/ml CSN1S1 and the expression of
CD14 and the M-CSF and GM-CSF receptors (CD115
and CD116, respectively) were determined by flow cytom-
etry and immunolabeling (Figure 4d). CSN1S1 lead to the
expected upregulation of CD14, while the expression of
CD115 and CD116 remained unchanged. The addition of
an M-CSF antibody to CSN1S1 stimulated primary human
monocytes in the same concentration that was demon-
strated to bind the secreted M-CSF protein (Figure 4c) did
not alter the expression of CD14 or the receptors CD115
and CD116. Thus, neither changes in the expression of
M-CSF, nor up- or downregulation of M-CSF receptor
(CD115) or GM-CSF receptor (CD116) respectively,
explained the preferential shift of monocyte differentiation
towards macrophages in culture conditions that contain
both M- and GM-CSF.
CSN1S1 induced differentiation and cytokine expression
may partially be mediated via MAPK
We previously reported that CSN1S1 upregulates the ex-
pression and secretion of GM-CSF in monocytes in a
p38 MAPK-dependent fashion [13]. We were therefore
interested to analyze if cellular differentiation and the
expression of other proinflammatory cytokines is also
dependent upon MAPK pathways. In a first step, we
analysed if addition of inhibitors of the MAPK pathways,
i.e. JNK, p38, and ERK, influenced overall survival of pri-
mary human monocytes. As can be seen in Figure 5a,
there was no significant effect on cellular vitality of
monocytes by addition of inhibitors for 24 h in the con-
centrations used in subsequent experiments. Next, we
assessed if the addition of these inhibitors was biologi-
cally effective in suppressing MAPK mediated signalling.

















































































































Figure 4 Characterization of CSN1S1 differentiated monocytes, and the role of M-CSF. a. phagocytic uptake of labelled zymosan particles
in an colorimetric assay of cells stimulated with 10 μg/ml CSN1S1 or medium control (mean and SD of 5 experiments). *, p < .05; **, p < .005,
two-sided t-test. b. Representative flow cytometry data of monocytes differentiated towards a dendritic cell phenotype by GM-CSF, and reversal
of differentiation by addition of CSN1S1 (representative data of 4 experiments). c. Stimulation of monocytes for 24 h with 10 μg/ml CSN1S1 in
the presence and absence of an anti M-CSF antibody demonstrates neutralization of secreted M-CSF by the antibody (mean and SD of 4
experiments. *, p < .05, t-test). d. Effect of M-CSF neutralization by an M-CSF antibody on expression of CD14 and the receptors of M-CSF (CD115)
or GM-CSF (CD116) (mean and SD of 4 experiments. *, p < .05, t-test).
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sion [22]. Therefore, primary human monocytes were
stimulated with LPS for 24 h in the presence and ab-
sence of MAPK inhibitors and IL-1b-mRNA expression
was measured as a control experiment. As can be seen
in Figure 5b, all inhibitors significantly suppressed IL-
1b-mRNA expression to a similar degree. In order to
identify a putative signal transduction mechanism re-
sponsible for CSN1S1-induced cellular differentiation,
we then tested the ability of MAPK inhibitors to impede
the generation of a macrophage-like phenotype. Primaryhuman monocytes were therefore incubated with MAPK
inhibitors before stimulation with 10 μg/ml CSN1S1. Cell
surface markers CD14 and CD64, upregulated during
CSN1S1-induced differentiation as described above, were
assessed by flow cytometry and immunolabeling. As de-
picted in Figure 5c, CSN1S1-mediated upregulation of
CD14 was significantly decreased by inhibition of ERK,
but not p38 and JNK. Next, we were interested to see if
this effect was specific for CSN1S1 stimulated cells or if
ERK-inhibition generally reduces CD14 expression in





































































































































































































































Figure 5 (See legend on next page.)
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Figure 5 The role of MAPK in CSN1S1 induced cellular differentiation. a. Effect of ERK1/2-, p38-, and JNK-Inhibitor (I) on cellular viability of
primary human monocytes. b. Significant suppression of LPS-induced IL-1b-mRNA production by addition of ERK1/2-, p38-, and JNK-I (mean and
SD of 4 experiments, p < 0.05, t-test). c-e. surface marker expression in primary human monocytes stimulated with 10 μg/ml CSN1S1 (c), M-CSF
(d), and GM-CSF (e) for 24 h in the presence of indicated MAPK-I (mean and SD of 4 experiments. * p < 0.05, ANOVA with Bonferroni correction).
f, g. Secretion of IL-1b (f) and IL-6 (g) protein into supernatants of primary human monocytes stimulated with CSN1S1 and indicated MAPK-I
(mean and SD of 4 experiments. * p < 0.05, ANOVA with Bonferroni correction). h. Western-blot of unphosphorylated and phosphorylated (p-)
p38-, JNK, and ERK-MAPK molecules in cell lysates of primary human monocytes stimulated for 24 h with 10 μg/ml CSN1S1. Images from P38
blots are separated, because protein samples were loaded in two pockets separated by an empty pocket due to blending of bands when
adjacent pockets were used.
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tion with M-CSF. As shown in Figure 5d, upregulations of
CD14 in M-CSF treated cells were not influenced by in-
hibition of ERK as in CSN1S1 treated cells, but by inhi-
bition of JNK. In contrast, MAPK inhibition did not
influence surface marker expression in cells stimulated
with GM-CSF for 24 h (Figure 5e). This suggests that sig-
nal transduction of CSN1S1-mediated differentiation is at
least in part distinct from pathways used by M-CSF.
In order to evaluate whether CSN1S1 induces the expres-
sion of proinflammatory cytokines via the same route, pri-
mary human monocytes were stimulated with CSN1S1 and
IL-1b and IL-6 protein-secretion into culture supernatants
was measured in the presence and absence of MAPK inhi-
bitors. As can be seen in Figure 5f-g, a significant reduction
in the upregulation of IL-1b was noted with inhibition of
p38 and JNK while IL-6 was decreased with inhibition of
JNK only. Of note, inhibition of ERK did not reduce in-
creased cytokine secretion in a significant manner.
The above results suggested that CSN1S1 engages all
3 MAPK molecules to either exert effects on cellular diffe-
rentiation or proinflammatory cytokine expression. To con-
firm this notion, we additionally assessed activation, i.e.
phosphorylation, of MAPK after incubation of primary
human monocytes with 10 μg/ml CSN1S1 for 24 h by
Western blot. As can be seen in Figure 5h, p38, JNK, and
ERK were all phosphorylated when stimulated with
CSN1S1, but not in control experiments without CSN1S1.
Discussion
In the present study, we demonstrate that exposure of pri-
mary human monocytes to CSN1S1 in vitro consistently
skews cellular differentiation towards macrophages, in-
cluding morphological changes, distinct surface marker
expression, and functional properties such as increased
phagocytic activity. Additionally, CSN1S1 induces the ex-
pression of proinflammatory cytokines [13]. Besides these
functions, the most obvious role of human CSN1S1 is to
provide an amino acid source to the new-born. However,
the acquisition of additional functionality in an evolutio-
nary context is an increasingly recognized phenomenon,
also referred to as protein promiscuity [23,24]. In accor-
dance with this notion, caseins are considered to have
arisen from innate immune genes, and that their nutritivefunctions are a consequence of a more recent evolutionary
development [25]. This assumption is based on the con-
served organization of the casein genes in a cluster of in-
nate immune genes that also includes the histatin/
statherin-family [25]. The hypothesis that CSN1S1 is a
multifunctional protein is further supported by its state as
a disordered protein with multiple potential tertiary con-
formations [26]. This last point has to be regarded with
caution however, since – to the best of our knowledge –
crystallographic analyses of the human CSN1S1 structures
currently do not exist. Since CSN1S1 is not only an en-
dogenous produced protein, but is also a component of
milk, the question arises, which potential functions
CSN1S1-induced IL-1β expression could have in the off-
spring. Intestinal exposure to antigens and milk constitutes
an important trigger for the development of a competent
immune system in the new-born [27]. It is therefore inter-
esting to speculate that CSN1S1 in mother milk may con-
tribute to the development of a patent immune system by
triggering immune responses to potential pathogens by ac-
tivation of innate immune responses like for instance IL-1β
secretion. Moreover, CSN1S1 by itself gives rise to
sustained specific IgG antibody production in nursed indi-
viduals [28]. Early infantile autoantibody production in turn
is speculated to confer protection to pathogens [29]. On
the other hand, there are several mechanisms which could
potentially prevent overwhelming inflammation triggered
by exposure to CSN1S1 in milk: CSN1S1 is only a minor
component of human milk and constitutes approximately
5% of the casein-fraction [30]. Moreover, CSN1S1 may be
degraded by proteases in the healthy gut, thereby preventing
IL-1β induction. Further research is clearly warranted to
clarify these exciting new hypotheses and to explore, if varia-
tions in CSN1S1 exposure or extra-mammary expression
may contribute to defective immune reactions. The recent
findings of CSN1S1 overexpression in the autoimmune dis-
eases multiple sclerosis and rheumatoid arthritis [9,10,12]
may be considered supportive of this hypothesis.
In the present experiments, the effect on all aspects of
cellular differentiation, i.e. change of morphology, surface
marker expression and increased phagocytosis, were ob-
served rapidly, within 24 h of stimulation. Furthermore,
CSN1S1 was able to reverse early GM-CSF-induced mono-
cyte differentiation into DC, resulting in a macrophage like
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macrophages or DC is most commonly carried out over 5
days, although more rapid differentiation in the course of
several hours is recognized depending on the stimulus
used [20]. In accordance with this notion, characteristic
differences between in vitro differentiation towards macro-
phages (using M-CSF/IFNγ) or DC (using GM-CSF/IL-4)
were observed after 120, but not 24 h. Of note, surface
markers were strikingly similar between M-CSF/IFNγ and
CSN1S1 treated cells. However, CSN1S1 failed to reverse
in vitro generation of early DC by a combination of GM-
CSF and IL-4. This may be due to the more potent effect
on in vitro DC generation by the combined cytokines com-
pared to GM-CSF alone [15,21,31].
We were consequently interested to explore potential
mechanisms employed by CSN1S1 to induce monocyte
differentiation and cytokine expression. It was previously
reported that primary human monocytes secrete GM-CSF
in response to CSN1S1 [13]. This was somewhat puzzling,
because GM-CSF is known to influence the differentiation
of monocytes towards a DC phenotype [21]. On the other
hand, according to the present data, CSN1S1 does also in-
crease the secretion of M-CSF into culture supernatants.
However, addition of a neutralizing M-CSF antibody to
stimulated monocytes did not abrogate CSN1S1-effects.
Importantly, there were also no changes in expression of
the GM-CSF- or M-CSF-receptors (CD115 or CD116, re-
spectively). Thus, CSN1S1 likely induces its effects on
monocyte differentiation by a mechanism independent
from M-CSF signalling. Concerning intracellular messen-
gers, CSN1S1, like other proinflammatory cytokines such
as IL-32 for example, employs p38 MAPK to induce
proinflammatory cytokine expression [13,19]. Inhibition of
another member of the MAPK family, ERK1/2, a well-
known regulator of cellular differentiation [32], but not p38
or JNK led to a decrease in CSN1S1 induced upregulation
of CD14 in the present experiments. This effect may be
specific for CSN1S1 rather than attributable to the process
of differentiation of monocytes towards macrophages in
general, because M-CSF induced upregulation of CD14 was
inhibited by JNK exclusively. Furthermore, in contrast to
differentiation, the secretion of proinflammatory cytokines
(i.e. IL-6 and IL-1b) was influenced by the inhibition of
JNK and/or p38, but not by ERK1/2. It cannot be excluded
that other second messengers are employed for CSN1S1 in-
duced cellular differentiation as well, especially because
CD64 was not significantly affected by ERK1/2 inhibition.
In conclusion, the data suggest that MAPK may be diffe-
rentially involved in mediating CSN1S1 induced effects on
cellular differentiation or cytokine expression. Further re-
search in this direction is warranted however, before firm
conclusions can be drawn.
A limitation to the study consists in the fact that the
concentration of CSN1S1 in potentially relevant tissuesfor monocyte differentiation such as e.g. inflamed nerves,
joints, or even the gastrointestinal tract is unknown. In
order to simulate physiologic conditions, the concentrations
of CSN1S1 used in the present experiments was determined
based on previous observations: While in vitro-experiments
suggest that ectopic CSN1S1 secretion by monocytes is in
the range of ng/ml [9,13], human milk contains 2.4 mg/ml
total casein [33], approximately 5% of which is made up of
CSN1S1 [30]. This results in a concentration of 120 μg/ml
CSN1S1. Although proteins contained in milk are exposed
to proteases within the digestive tract, they may be
absorbed in an intact form which is even favoured by im-
mature digestive functions of infants and protease inhibi-
tors within milk [34]. Thus, concentrations used in the
present experiments may reflect local conditions in vivo.
Conclusions
Human CSN1S1 influences the differentiation of mono-
cytes towards macrophages in vitro and mediates the ex-
pression of proinflammatory cytokines. This process is at
least partially dependent on differential MAPK signalling.
The notion of CSN1S1 as a multifunctional protein with
immunomodulatory properties beyond nutritional aspects
is further evolving.
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